-CNBC’s “Fast Money: Halftime Report”
Vaxart Stock Crosses 2 Key Levels Friday: What’s Next?
Vaxart Inc. (NASDAQ: VXRT) shares were trading higher Friday after the company plans to test the cross-reactivity of its oral tablet COVID-19 vaccine candidate against the omicron SARS-CoV-2 variant in two studies expected to begin next month.